Park Jin Hyuk said to Mao Dayong:

"We don't care how much it costs to invite Nam Byung-chan to work for DS. If 1 billion (about 5.3 million RMB) isn't enough, then 2 billion. If 2 billion isn't enough, then 3 billion. But we have to make it clear that this is performance-based pay. Only those who do well can earn this much."

"Chairman, he's just a deputy editor of a newspaper. Is it necessary to spend so much money?"

"Not much. If we make good use of this person, we can create much more value than this."

"I understand. I'll be leaving now."

Mao Dayong bowed and walked out of the office.

Park Jin Hyuk felt that Mao Dayong did not understand his deep meaning.

He picked up the coffee, took a sip, and then said to Jin Junyu:

"Have you investigated?"

"We've investigated and found that Nan Bingzan and the current editor-in-chief are not on good terms. The editor-in-chief, who was his junior in college, was promoted to editor-in-chief, which is why he's very unhappy."

"So that's how it is. Tell President Mao to stop intervening in Nan Bingzan's affairs. Contact Nan Bingzan directly and recruit him to DS Telecom. As for the position... give him the title of Brand Promotion Director, and have him report directly to me."

"Want to recruit him to DS Communications?"

"Well, remember to include a clause in the contract so we can kick him out at any time."

"Will he agree?"

In the face of huge interests, people will lose their rationality and normal thinking ability.

"Because the temptation isn't big enough, he's hesitant and overthinking. If the temptation is big enough, people like him won't think so much."

After accepting the task, Jin Junyu walked out of the office.

In a blink of an eye, three days passed.

Nam Byung-chan came to Park Jin-hyuk's office.

"Hello, Chairman Park! Nice to meet you."

Nan Bingzan came up and bowed 90 degrees.

Money makes the world go round. In the face of money and interests, Nan Bingzan surrendered so quickly.

This time, in order to bring Nam Byung-chan to DS Telecom, he was promised a compensation of 5 billion (about 26.5 million RMB), which is equivalent to 40 to 50 times his annual salary.

Park Jin Hyuk smiled and said:

"Welcome, welcome."

"Chairman, I'm truly sorry. I said something I shouldn't have said. Please forgive me. That wasn't my intention. Premier Wang asked me to do that."

Park Jin Hyuk walked over, shook Nam Byung Chan's hand, and said:

"Don't take it to heart. I'll leave everything else to you."

"Please rest assured, leave the external publicity and public opinion response to me."

"With your words, I feel at ease. You can discuss the specific work with Director Jin."

"Thank you so much."

Nam Byung-chan bowed to Park Jin-hyuk again and walked out.

*** *** ***

Because Nam Byung-chan joined the DS Group, the intensity of Silla Ilbo's attacks on Park Jin-hyuk was significantly weakened.

The same is true for other media outlets influenced by the Shilla Daily.

The people standing in the front waving flags and cheering suddenly disappeared, and the people behind them suddenly lost their direction.

People have raised the question of why vaccine development has been slow to progress?

At this moment, shocking news came from abroad.

[The U.S. CDC Influenza Pandemic Special Management Project Team will visit South Korea soon]

People began to talk about it.

"I heard that the number of flu patients in the United States has exceeded 500,000, and the death toll has reached 30,000. Especially for people over 50 years old, the mortality rate is as high as 50%."

“It’s horrible.”

"I heard they came to Korea for the DS Pharmaceutical vaccine."

"Didn't they say that vaccine development has been stopped?"

"Yes, the newspaper said that because the vaccine has not been fully verified, there are very serious hidden dangers."

“…The side effects of the vaccine are going to be very significant.”

They all took the report of the Silla Daily as fact.

But at this time, there was a scene of panic in the Silla Daily News.

The editor-in-chief is convening a meeting of more than 10 reporters, all of whom are members of the special reporting team on the epidemic.

"Editor-in-Chief, still can't contact Deputy Editor-in-Chief Nan?"

The person in charge of the special reporting team on the epidemic was originally Nan Bingzan.

Because he suddenly resigned and went to DS Communications, the editor-in-chief had to temporarily take charge of the reporting team.

"I can't get in touch with him. He went to DS."

"Could it be that he keeps scolding DS just to create this kind of opportunity for himself?"

"Who knows? We can only ask him."

Nam Byung-chan, who had been criticizing DS Group, suddenly went to DS, which surprised everyone.

"After interviewing DS Pharmaceuticals, where will we go next? Will it be Hancheng Pharmaceuticals?"

Because Hancheng Pharmaceutical is responsible for producing Bidaphil, he believes the US CDC will go there later.

However, the reporters shook their heads.

"No, I'll go to DS Pharmaceuticals tomorrow."

"Why?"

"The Ministry of Health and Welfare said...the U.S. CDC came to Korea specifically to target DS Pharmaceuticals."

"What? You're here for DS Pharmaceuticals?"

"They only plan to meet with DS Pharmaceuticals and have no plans to visit other companies."

"What about the Ministry of Health and Welfare?"

“There are no meetings scheduled with the Ministry of Health and Welfare. Their only target is DS Pharmaceuticals.”

The editor-in-chief looked at the reporters present.

He immediately realized the truth that the reporters had not told him.

“Is the CDC planning to bring vaccine research and development to the United States this time?”

This chapter is not finished yet, please click on the next page to continue reading the exciting content!